Loading…
Astellas Pharma Inc. announced it will acquire Iota Biosciences, Inc., a start-up company with unique ultrasonic-powered bioelectronic devices technology. The acquisition is expected to accelerate Astellas' Rx+ business by acquiring innovative technology for ultra-small implantable medical devices.